Publications

Export 113 results:
[ Auteur(Asc)] Title Type Année
Filtres: First Letter Of Last Name is G  [Enlever les filtres]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Gerretsen P, Menon M, M Chakravarty M, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Germann J, Petrides M, M Chakravarty M.  2019.  Hand preference and local asymmetry in cerebral cortex, basal ganglia, and cerebellar white matter.. Brain Struct Funct. 224(8):2899-2905.
Georgiou P, Zanos P, Garcia-Carmona J-A, Hourani S, Kitchen I, Kieffer BL, Laorden M-L, Bailey A.  2015.  The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: Involvement of dopaminergic, noradrenergic and MOPr systems.. Eur Neuropsychopharmacol. 25(12):2459-64.
Georgiades S, Boyle M, Szatmari P, Hanna S, Duku E, Zwaigenbaum L, Bryson S, Fombonne E, Volden J, Mirenda P et al..  2014.  Modeling the phenotypic architecture of autism symptoms from time of diagnosis to age 6.. J Autism Dev Disord. 44(12):3045-55.
Geoffroy M-C, Turecki G.  2016.  The developmental course of suicidal ideation in first-episode psychosis.. Lancet Psychiatry. 3(5):395-6.
Geoffroy M-C, Boivin M, Arseneault L, Turecki G, Vitaro F, Brendgen M, Renaud J, Séguin JR, Tremblay RE, Côté SM.  2016.  Associations Between Peer Victimization and Suicidal Ideation and Suicide Attempt During Adolescence: Results From a Prospective Population-Based Birth Cohort.. J Am Acad Child Adolesc Psychiatry. 55(2):99-105.
Geoffroy M-C, Boivin M, Arseneault L, Renaud J, Perret LC, Turecki G, Michel G, Salla J, Vitaro F, Brendgen M et al..  2018.  Childhood trajectories of peer victimization and prediction of mental health outcomes in midadolescence: a longitudinal population-based study.. CMAJ. 190(2):E37-E43.
Geoffroy M-C, Pereira SPinto, Li L, Power C.  2016.  Child Neglect and Maltreatment and Childhood-to-Adulthood Cognition and Mental Health in a Prospective Birth Cohort.. J Am Acad Child Adolesc Psychiatry. 55(1):33-40.e3.
Gentil L, Grenier G, Bamvita JMarie, MJ Fleury.  2019.  Satisfaction with health and community services among homeless and formerly homeless individuals in Quebec, Canada.. Health Soc Care Community.
Gentil L, Grenier G, Bamvita JM, Dorvil H, MJ Fleury.  2019.  Profiles of Quality of Life in a Homeless Population. Frontiers in Psychiatry.
Ge Y, Tian M, Liu L, Wong TPan, Gong B, Wu D, Cho T, Lin S, Kast J, Lu J et al..  2019.  p97 regulates GluA1 homomeric AMPA receptor formation and plasma membrane expression.. Nat Commun. 10(1):4089.
Gauthier S, Schlaefke S.  2014.  Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.. Clin Interv Aging. 9:2065-77.
Gauthier S, Rosa-Neto P, Kass JS.  2016.  Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients.. Continuum (Minneap Minn). 22(2 Dementia):615-8.
Gauthier S, Herrmann N, Rosa-Neto P.  2018.  Optimal use of cholinergic drugs in Alzheimer's disease.. Brain.
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT.  2016.  Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 12(1):60-4.
Gauthier S, Ng KPin, Pascoal TA, Mathotaarachchi S, Chung C-O, Benedetti AL, Shin M, Kang MSu, Li X, Ba M et al..  2017.  Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 89(18):1931.
Gauthier S.  2017.  Research update on Alzheimer's disease and introduction to the Expert Review of Neurotherapeutics special issue.. Expert Rev Neurother. 17(1):1-2.
Gauthier S, Proaño JVoltaire, Jia J, Froelich L, Vester JChristophe, Doppler E.  2015.  Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.. Dement Geriatr Cogn Disord. 39(5-6):332-47.
Gauthier S, Robillard J, de Champlain J.  2017.  Progress in transnational scientific and ethics review: Commentary on the proposal for a single North American review board for research on dementia.. Alzheimers Dement.
Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.  2015.  Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.. J Alzheimers Dis. 48(2):473-81.
Gauthier S, Ng KPin, Pascoal TA, Zhang H, Rosa-Neto P.  2018.  Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.. J Alzheimers Dis.
Gauthier S, Leuzy A, Rosa-Neto P.  2014.  How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease? Neurodegener Dis. 13(2-3):197-9.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.
Gaumer B, MJ Fleury.  2008.  CLSCs in Quebec: thirty years of community action.. Soc Work Public Health. 23(4):89-106.
Gariépy G, Iyer SN.  2018.  The Mental Health of Young Canadians Who Are Not Working or in School.. Can J Psychiatry. :706743718815899.

Pages